`
`Inter Partes Review of USP 9,006,224
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED
`
`Petitioner
`
`V.
`
`NOVARTIS AG
`
`Patent Owner
`
`Patent No. 9,006,224
`
`Inter Partes Review No.: Unassigned
`
`PETITIONER WEST-WARD PHARMACEUTICALS INTERNATIONAL
`
`LIMITED’S POWER OF ATTORNEY FOR PETITION FOR INTER
`
`PARTES REVIEW OF U.S. PATENT NO. 9,006,224
`
`
`
`
`
`
`
`
`
`
`West-Ward Pharm. Int’l. Ltd.
`Inter Partes Review of USP 9,006,224
`
`Petitioner West-Ward Pharmaceuticals International Limited hereby appoints
`
`the following practitioners as its attorneys to act on its behalf in all matters
`
`associated with the above-captioned Petition for Inter Partes Review of U.S. Patent
`
`No. 9,006,224.
`
`Lead counsel
`Keith A. Zullow (Reg. No. 37,975)
`kzullow@goodwinprocter.com
`Goodwin Procter LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018-1405
`T: 212-813-8846; F: 646-558-4226
`
`
`Back-up Counsel
`Marta E. Delsignore (Reg. No. 32,689)
`mdelsignore@goodwinprocter.com
`Goodwin Procter LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018-1405
`T: 212-813-8822; F: 646-558-4079
`
`
`
`1
`
`
`
`West-Ward Pharm. Int’1. Ltd.
`
`Inter Partes Review of USP 9,006,224
`
`The individua1(s) signing below has the authority to execute this document
`
`on behalf of West-Ward Pharmaceuticals International Limited.
`
`By:
`Name: ggm, fiffmamh
`
`Title: Drfecflfi
`
`Date:
`
`/3 Mac @121 Z
`
`
`
`
`
`
`
`
`
`
`
`
`West-Ward Pharm. Int’l. Ltd.
`Inter Partes Review of USP 9,006,224
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that on March 13, 2017, a copy of the
`
`foregoing Petitioner West-Ward Pharmaceuticals International Limited’s
`
`“Petitioner Power Of Attorney For Petition For Inter Partes Review Of U.S. Patent
`
`No. 9,006,224” (“the ’224 patent”) was served in its entirety on the Patent Owner
`
`by serving via overnight delivery to the correspondence address of record for the
`
`owners of the ’224 patent and litigation counsel for Novartis AG in C.A. No.
`
`15-474-RGA, D.Del. and via Federal Express International Priority to Novartis AG:
`
`Novartis Pharmaceutical Corporation
`Intellectual Property Department
`Attn: Peter J. Waibel, Esq. (Head of Patent Litigation)
`One Health Plaza 433/2
`East Hanover, NJ 07936-1080
`
`Nicholas Kallas
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`New York, NY 10104-3800
`
`Novartis International AG
`Novartis Campus
`Attn: Alisa A. Harbin, Esq. (Head, Group Litigation and Intellectual
`Property)
`Forum 1-1.20
`Basel, CH-4002 SWITZERLAND
`
`
`
` /Keith A. Zullow/
`Keith A. Zullow
`Reg. No. 37,975
`GOODWIN PROCTER LLP
`
`
`March 13, 2017
`
`
`
`
`
`
`
`
`